Form 4: HealthEquity EVP, Chief Technology Officer, Elimelech Rosner, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Elimelech Rosner, EVP and Chief Technology Officer of HealthEquity, Inc., reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On March 27, 2024, Elimelech Rosner, the EVP and Chief Technology Officer of HealthEquity, Inc., reported changes in beneficial ownership.
- Rosner acquired 18,816 shares of common stock at $0.
- Rosner disposed of 80,499 shares of common stock.
- The filing also details restricted stock units that vest over time, starting with 25% on April 1, 2025, and then 6.25% each quarter for the following twelve quarters.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting changes in stock ownership. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock ownership.
- It can influence investor perception of management's alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction for common stock acquisition and disposal. |
| 04/01/2025 | First vesting date for 25% of the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.